Using Artificial Intelligence (AI) on standards and related intellectual property is strongly prohibited. In the event of a violation, your access to the standards will be revoked.
BS EN 14348 Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of tuberculocidal or mycobactericidal activity in the medical area. Test methods and requirements (phase 2, step 1)
Format
Availability
Price and currency
English Secure PDF
Immediate download
Printable - You are authorized to print 1 copy
27.53 USD
English Hardcopy
In stock
27.53 USD
Standard number:
26/30548611 DC
Pages:
59
Released:
2026-10-29
Status:
Draft for Comment
DESCRIPTION
26/30548611 DC
This standard 26/30548611 DC BS EN 14348 Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of tuberculocidal or mycobactericidal activity in the medical area. Test methods and requirements (phase 2, step 1) is classified in these ICS categories:
11.080.20 Disinfectants and antiseptics
This document specifies a test method and the minimum requirements for mycobactericidal (or tuberculocidal) activity of chemical disinfectant products that form a homogeneous, physically stable preparation when diluted with hard water - or in the case of ready-to-use products - with water. Products can only be tested at a concentration of 80 % or less as some dilution is always produced by adding the test organisms and interfering substance. This document applies to products that are used in the medical area including those that are covered by the EEC/93/42 Directive on Medical Devices. This document applies to areas and situations where disinfection is medically indicated. Such indications occur in patient care, for example: - in hospitals, in community medical facilities and in dental institutions; - in clinics of schools, of kindergardens and of nursing homes; and may occur in the workplace and in the home. It may also include services such as laundries and kitchens supplying products directly for the patients. NOTE 1 The method described is intended to determine the activity of commercial formulations or active substances under the conditions in which they are used. NOTE 2 This method corresponds to a phase 2, step 1 test (see Annex E).